Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/LIVZON-PHARMACEUTICAL-GRO-13491325/nieuws/Livzon-MABPharm-Inc-kondigt-de-opname-aan-van-het-Recombinant-SARS-COV-2-Bivalent-Original-Omicron-45502799/?utm_source=whatsapp&utm_medium=social&utm_campaign=share